Skeletal muscle-derived cell implantation for the treatment of fecal incontinence: a multicenter, randomized, double-blind, placebo controlled, parallel-group, dose-finding clinical study
Phase of Trial: Phase II
Latest Information Update: 18 Aug 2017
At a glance
- Drugs ICEF 15 (Primary)
- Indications Faecal incontinence
- Focus Therapeutic Use
- Acronyms STEFFI
- Sponsors Innovacell Biotechnologie GmbH
- 16 Aug 2017 This study has been discontinued in Slovenia (end date: 2017-08-04) as per European Clinical Trials Database.
- 11 Aug 2017 This study has been discontinued in Germany as per European Clinical Trials Database.
- 21 Apr 2015 New trial record